Biowave

Norwalk, United States Founded: 2000 • Age: 26 yrs
Neuromodulation devices are developed for pain therapy management.

About Biowave

Biowave is a Healthcare company based in Norwalk (United States) founded in 2000. Neuromodulation devices are developed for pain therapy management. Biowave has raised $2.08 million across 2 funding rounds. Biowave offers products and services including BioWavePRO, BioWavePENS, BioWaveHOME, BioWaveGO RX, and BioWraps. Its focus areas include Life Sciences, Pain Management, Medical Devices and Therapeutic Devices. Its legal entity is BioWave Corporation. Its competitors include Saluda Medical, Nalu Medical and Myoscience; 3 of its 3 listed competitors have raised funding.

Company details

Biowave Corporation develops and markets neuromodulation pain therapy devices aiming to aid physicians, physical therapists, and athletic trainers manage their patients or athletes pain and reduce the use of drugs. The BiowavePRO and Homewave neuromodulation devices deliver a therapeutic electrical pulse into deep tissue in the body blocking the transmission of pain. The devices have received marketing clearance from the FDA (Sep 2015) and are indicated to treat musculoskeletal pain that is chronic, acute or post-operative in nature and located in the low back, cervical spine, shoulder, elbow, wrist, hand, hip, knee, ankle and foot.

  • Headquarters Norwalk, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website biowave.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Biowave Corporation
Key Metrics
  • Total Equity Funding
    $2.08M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.33M (USD), Seed

    Dec 2019

Products & Services of Biowave

Biowave offers a comprehensive portfolio of products and services, including BioWavePRO, BioWavePENS, BioWaveHOME, BioWaveGO RX, and BioWraps.

BioWavePRO
Neurostimulation Device

Wearable device for blocking severe pain in medical settings.

BioWavePENS
Nerve Stimulation Tool

Non-surgical treatment providing up to 72 hours of pain relief.

BioWaveHOME
Home Pain Relief Device

Portable neurostimulation for personal chronic pain management.

BioWaveGO RX
Wearable Pain Blocker

Compact device offering up to 24 hours of fast pain relief.

BioWraps
Electrode Garment

Wearable compression for treating larger tissue areas with relief.

Apps and channels of Biowave

Biowave publishes 2 mobile apps with over 1K+ downloads; its YouTube channel BioWave has 343 subscribers and 30 videos.

BioWave+
Google Play Health & Fitness Everyone Free
Developer: Biowave Corporation
View on Google Play
BioWave+
App Store Medical 4+
Developer: Biowave Corporation
View on App Store
BioWave
YouTube 343 subscribers 30 videos Science & Technology
Open channel

Videos from Biowave

The most watched videos on Biowave's YouTube channel, BioWave (343 subscribers). Click a video to play it here.

Why Choose BioWave for Immediate Long Lasting Pain Relief
1.5K views
BioWave Pain Treatment Applications Using Foot/Ankle BioWraps: Podiatric Practices & Other Providers
855 views
Pain Treatment Applications Using Foot/Ankle BioWraps
740 views
Effective Pain Relief for Patients: High-Frequency Percutaneous Neurostimulation - BioWavePENS
590 views

More on BioWave.

Funding Insights of Biowave

Biowave has successfully raised a total of $2.08M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.33 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.08M
  • Total Rounds 2
  • Last Round Seed β€” $1.33M
  • First Round $749,429

    (Jan 2016)

All 2 funding rounds of Biowave with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2019$1.33MSeed––
–
Jan 2016$749,429Seed––
–

People of Biowave

17 people are tracked at Biowave (5 in leadership, 7 in board & advisors, 5 in team).

NameRoleGroup
Rob Wolter
CEOLeadership
Tijana Radinkovic
Director Of Customer ServiceLeadership
John Carter
Director of R&DLeadership
Will Seely
Director of OperationsLeadership
Sean Moran
Senior Director Of Operations & Supply ChainLeadership
Raymond Tatevossian
AdvisorBoard & advisors
Michael A. Fishman
AdvisorBoard & advisors
Alaa Abd-Elsayed
AdvisorBoard & advisors
Nolan A. Maher
AdvisorBoard & advisors
Rob Adler
ChairmanBoard & advisors
Charles Odonkor
AdvisorBoard & advisors
Dominic Hegarty
AdvisorBoard & advisors
Tommy Rodriguez
Operations, Fulfillment SpecialistTeam
Jarrett Kycia
Quality AnalystTeam
Sydnie H.
Corporate Business AnalystTeam
Tia Cavone
Operations ManagerTeam
Ania Kuniej
Sales Operations SpecialistTeam
Premium access

Complete people profiles for Biowave

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Biowave

3 dated milestones of Biowave across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Biowave is founded.
  2. Funding First funding round of $749K.
  3. Funding Latest funding round, Seed, of $1.3M.

Competitors of Biowave

Biowave has 3 listed competitors in our database, 3 of them funded. They include Saluda Medical, Nalu Medical and Myoscience.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
saludamedical.com2010Bloomington, United States$500M
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment
nalumed.com2014Carlsbad, United States$230.97M
Developer of a neurostimulation system for managing intractable chronic pain
myoscience.com2005Redwood, United States$147.68M687
Technology-driven dermatological products are developed and commercialized.
Premium access

Detailed competitors of Biowave

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Biowave

The website of Biowave (biowave.com) receives about 6.2K visits a month.

  • Monthly visits
    6.2K

    ▲ 18.9% vs previous month

Similar websites

Websites whose visitors overlap most with Biowave. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
orthomedical.co.uk
orthomedical.co.uk
100%
–
medzonecorp.com
medzonecorp.com
98%
#7,243,891–
medi-stim.com
medi-stim.com
98%
#2,702,799–
alleviahealth.com
79%
#5,299,424View details
rife.de
rife.de
76%
#14,349,277–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Biowave

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Pain Management

3 companies that operate in the same segment as Biowave (Pain Management) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Developer of therapeutics for pain relief and inflammatory diseases
2004New York, New York, United StatesUSD 51 MUSD 4.33 M79
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed.
2007Philadelphia, Pennsylvania, United StatesUSD 203 MUSD 3.13 M35
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biowave

Premium access

Complete news archive for Biowave

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biowave

Biowave was founded in 2000 and raised its 1st funding round 16 years after it was founded.

Biowave is headquartered in Norwalk, United States.

Biowave is a funded company, having raised a total of $2.08M across 2 funding rounds to date. The company's 1st funding round was a Seed of $749.43K, raised on Jan 2016.

Biowave Corporation develops and markets neuromodulation pain therapy devices aiming to aid physicians, physical therapists, and athletic trainers manage their patients or athletes pain and reduce the use of drugs. The BiowavePRO and Homewave neuromodulation devices deliver a therapeutic electrical pulse into deep tissue in the body blocking the transmission of pain. The devices have received marketing clearance from the FDA (Sep 2015) and are indicated to treat musculoskeletal pain that is chronic, acute or post-operative in nature and located in the low back, cervical spine, shoulder, elbow, wrist, hand, hip, knee, ankle and foot.

Biowave's top competitors include Saluda Medical, Nalu Medical and Myoscience.

Biowave offers BioWavePRO, BioWavePENS, BioWaveHOME, BioWaveGO RX, and BioWraps.

Biowave operates through Biowave Corporation.

Yes. Biowave publishes BioWave+ and 1 more app, with over 1,000 downloads.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available